Cigna Healthcare will begin providing coverage for RhinAer® treatment of the posterior nasal nerve (CPT 31242), effective September 15, 2025. This policy change removes RhinAer from Cigna's list of procedures previously deemed experimental, investigational, and unproven.
This decision marks a significant step forward in expanding access to a minimally invasive solution for patients suffering from chronic nasal conditions. RhinAer offers a best-in-class treatment option, and its inclusion in Cigna's coverage policy will benefit many members.
The move reflects Cigna's ongoing evaluation of new medical technologies and its commitment to covering clinically effective treatments. By enabling coverage for RhinAer, Cigna enhances its healthcare offerings and supports improved patient outcomes for chronic rhinitis.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.